NCT04939220

Brief Summary

Increasingly, transesophageal echos (TEEs) are being done on high risk patients. A TEE is a short procedure done with deep sedation, but poses an increased risk of apnea/ hypoxemia in those with pulmonary disease. It is desirable to avoid intubation, which adds risk. Use of supraglottic airway (SGA) may offer an alternative. The investigators hypothesize that TEEs can be done successfully with an SGA in place. The investigators propose a prospective RCT to compare TEE exams done with deep sedation to those done with an SGA.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 25, 2021

Completed
2.6 years until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2024

Completed
Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

1 month

First QC Date

May 24, 2021

Last Update Submit

June 18, 2024

Conditions

Keywords

TEESGAAnesthesiasedationChronic Hypoxemic lung DiseaseObstructive Sleep ApneaMorbid Obesity

Outcome Measures

Primary Outcomes (1)

  • The number of successfully completed TEE examinations with the assigned airway intervention

    The primary outcome is a binary data point (yes/no) defined as the success of using the assigned LMA or natural airway successfully for a TEE procedure.

    Duration of procedure

Secondary Outcomes (10)

  • Ease of Placement of LMA

    Duration of procedure

  • Alternative Airway device

    Duration of procedure

  • Dislocation of LMA

    Duration of procedure

  • Chin Lift or Jaw Thrust

    Duration of Procedure

  • Pharyngeal Bleeding

    Duration of Procedure

  • +5 more secondary outcomes

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Deep sedation with propofol and natural airway

Procedure: TEE with Deep Sedation

Experimental Group

EXPERIMENTAL

SGA Placement and maintenance with inhalational anesthetic or propofol

Procedure: TEE with SGA

Interventions

TEE with SGAPROCEDURE

SGA Placement and maintenance with inhalational anesthetic or propofol

Experimental Group

Deep sedation with propofol and natural airway

Control Group

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults presenting for elective outpatient TEE examinations at UF Shands hospital during the study duration

You may not qualify if:

  • Known or suspected difficult airway, patient refusal or inability to consent, patients to have emergent or urgent TEE exams, patients considered to have full stomach ie gastroparesis or achalasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UF Health Jacksonville

Jacksonville, Florida, 32209, United States

Location

Related Publications (12)

  • Chiew WA, Chen Q, Tan LZ. Use of LMAⓇ GastroTM in esophagogastroduodenoscopy and endoscopy. Korean J Anesthesiol. 2019 Dec;72(6):618-619. doi: 10.4097/kja.19163. Epub 2019 Jul 1. No abstract available.

    PMID: 31257818BACKGROUND
  • Terblanche NCS, Middleton C, Choi-Lundberg DL, Skinner M. Efficacy of a new dual channel laryngeal mask airway, the LMA(R)Gastro Airway, for upper gastrointestinal endoscopy: a prospective observational study. Br J Anaesth. 2018 Feb;120(2):353-360. doi: 10.1016/j.bja.2017.11.075. Epub 2017 Dec 1.

    PMID: 29406183BACKGROUND
  • Tran A, Thiruvenkatarajan V, Wahba M, Currie J, Rajbhoj A, van Wijk R, Teo E, Lorenzetti M, Ludbrook G. LMA(R) Gastro Airway for endoscopic retrograde cholangiopancreatography: a retrospective observational analysis. BMC Anesthesiol. 2020 May 13;20(1):113. doi: 10.1186/s12871-020-01019-5.

    PMID: 32404136BACKGROUND
  • Schmutz A, Loeffler T, Schmidt A, Goebel U. LMA Gastro airway is feasible during upper gastrointestinal interventional endoscopic procedures in high risk patients: a single-center observational study. BMC Anesthesiol. 2020 Feb 8;20(1):40. doi: 10.1186/s12871-020-0938-9.

    PMID: 32035477BACKGROUND
  • Hakim M, Bryant J, Miketic R, Williams K, Erdman SH, Shafy SZ, Kim SS, Tobias JD. Clinical Outcomes of a Modified Laryngeal Mask Airway (LMA(R) Gastro Airway) During Esophagogastroduodenoscopy in Children and Adolescents: A Randomized Study. Med Devices (Auckl). 2020 Sep 21;13:277-282. doi: 10.2147/MDER.S272557. eCollection 2020.

    PMID: 33061677BACKGROUND
  • Waruingi D, Mung'ayi V, Gisore E, Wanyonyi S. A randomised controlled trial of the effect of laryngeal mask airway manometry on postoperative sore throat in spontaneously breathing adult patients presenting for surgery at a university teaching hospital. Afr Health Sci. 2019 Mar;19(1):1705-1715. doi: 10.4314/ahs.v19i1.47.

    PMID: 31149001BACKGROUND
  • Seet E, Yousaf F, Gupta S, Subramanyam R, Wong DT, Chung F. Use of manometry for laryngeal mask airway reduces postoperative pharyngolaryngeal adverse events: a prospective, randomized trial. Anesthesiology. 2010 Mar;112(3):652-7. doi: 10.1097/ALN.0b013e3181cf4346.

    PMID: 20179502BACKGROUND
  • Balmforth D, Smith A, Nagore D, Schilling R, O'Brien B. Can Transesophageal Echocardiography Be Performed Safely Using a Laryngeal Mask Airway During Atrial Fibrillation Ablation? J Cardiothorac Vasc Anesth. 2018 Apr;32(2):790-795. doi: 10.1053/j.jvca.2017.10.040. Epub 2017 Nov 2.

    PMID: 29229253BACKGROUND
  • Salvi L, Pepi M. Pressure-assisted breathing through a laryngeal mask airway during transesophageal echocardiography. Anesth Analg. 1999 Dec;89(6):1591-2. doi: 10.1097/00000539-199912000-00070. No abstract available.

    PMID: 10589667BACKGROUND
  • Ferson D, Thakar D, Swafford J, Sinha A, Sapire K, Arens J. Use of deep intravenous sedation with propofol and the laryngeal mask airway during transesophageal echocardiography. J Cardiothorac Vasc Anesth. 2003 Aug;17(4):443-6. doi: 10.1016/s1053-0770(03)00147-2.

    PMID: 12968230BACKGROUND
  • Patrick Mayr N, Michel J, Wiesner G, Rumpf PM. Supraglottic airway device use for transoesophageal echocardiography during left atrial appendage occlusion. Anaesthesia. 2019 Mar;74(3):405-406. doi: 10.1111/anae.14597. No abstract available.

    PMID: 30734949BACKGROUND
  • Saxena S, Aminian A, Nahrwold DA, Daper A. LMA Gastro Airway Seen Through the Eyes of a Cardiac Anesthesiologist. J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2365-2366. doi: 10.1053/j.jvca.2019.04.014. Epub 2019 Apr 20. No abstract available.

    PMID: 31101507BACKGROUND

Related Links

MeSH Terms

Conditions

Pulmonary Heart DiseaseSleep Apnea, ObstructiveObesity, Morbid

Interventions

Deep Sedation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia and Analgesia

Study Officials

  • Stefan Braunecker, MD, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Randomization to control group- deep sedation with propofol and natural airway or Experimental group-SGA Placement and maintenance with inhalational anesthetic or propofol.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2021

First Posted

June 25, 2021

Study Start

February 1, 2024

Primary Completion

March 9, 2024

Study Completion

March 9, 2024

Last Updated

June 21, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations